131 related articles for article (PubMed ID: 8841589)
21. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
[TBL] [Abstract][Full Text] [Related]
22. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
Biro S; Fu YM; Yu ZX; Epstein SE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
[TBL] [Abstract][Full Text] [Related]
24. Post-transcriptional control of bacteriophage T4 gene 25 expression: mRNA secondary structure that enhances translational initiation.
Nivinskas R; Malys N; Klausa V; Vaiskunaite R; Gineikiene E
J Mol Biol; 1999 May; 288(3):291-304. PubMed ID: 10329143
[TBL] [Abstract][Full Text] [Related]
25. RNA hairpin invasion and ribosome elongation arrest by mixed base PNA oligomer.
Dias N; Sénamaud-Beaufort C; Forestier El El; Auvin C; Hélène C; Ester Saison-Behmoaras T
J Mol Biol; 2002 Jul; 320(3):489-501. PubMed ID: 12096905
[TBL] [Abstract][Full Text] [Related]
26. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
[TBL] [Abstract][Full Text] [Related]
27. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
Fei R; Shaoyang L
Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
Sallot M; Lascombe I; Bermont L; Jouvenot M
Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
30. Hybridisation of [76Br]-labelled antisense oligonucleotides to Chromogranin A mRNA verified by RT-PCR.
Wu F; Lendvai G; Yngve U; Eriksson B; Långström B; Bergström M
Nucl Med Biol; 2004 Nov; 31(8):1073-8. PubMed ID: 15607489
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
Fujimoto K; Takahashi M
Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
[TBL] [Abstract][Full Text] [Related]
32. An antisense/target RNA duplex or a strong intramolecular RNA structure 5' of a translation initiation signal blocks ribosome binding: the case of plasmid R1.
Malmgren C; Engdahl HM; Romby P; Wagner EG
RNA; 1996 Oct; 2(10):1022-32. PubMed ID: 8849778
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of regulation of hepatoma cell cycle by XPD/P44 subcomplex : an in vitro experiment].
Wang HY; Xiong GF; Wu BL; Zhang JX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1997-2001. PubMed ID: 19062744
[TBL] [Abstract][Full Text] [Related]
34. Programmed cell death by hok/sok of plasmid R1: processing at the hok mRNA 3'-end triggers structural rearrangements that allow translation and antisense RNA binding.
Franch T; Gultyaev AP; Gerdes K
J Mol Biol; 1997 Oct; 273(1):38-51. PubMed ID: 9367744
[TBL] [Abstract][Full Text] [Related]
35. [Study on the antisense inhibition effect of liposome-mediated radiolabled antisense oligonucleotides of c-myc mRNA].
Zheng J; Tan T; Pan W; Zhang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):413-6. PubMed ID: 12910676
[TBL] [Abstract][Full Text] [Related]
36. Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5' untranslated region.
Cencig S; Nanbru C; Le SY; Gueydan C; Huez G; Kruys V
Oncogene; 2004 Jan; 23(1):267-77. PubMed ID: 14712232
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligodeoxynucleotides downregulated c-sis mRNA expression to inhibit proliferation of vascular smooth muscle cells.
Tang QD; Lin SG; Yu XY
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):36-42. PubMed ID: 10437122
[TBL] [Abstract][Full Text] [Related]
38. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
39. [Inducing apoptosis of HeLa cell lines by transfection of c-myc antisense oligonucleotides].
Li RR; Ma DX; Cheng YF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):19-22. PubMed ID: 16468633
[TBL] [Abstract][Full Text] [Related]
40. DLX-7 homeobox gene regulates c-myc and GATA-1 gene expression in different stages respectively.
Shimamoto T; Ohyashiki K; Takeshita K
Int J Oncol; 1999 Aug; 15(2):307-13. PubMed ID: 10402242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
